HC Wainwright & Co. Maintains Buy on Korro Bio, Raises Price Target to $115

Benzinga · 10/18 11:00
HC Wainwright & Co. analyst Mitchell Kapoor maintains Korro Bio (NASDAQ:KRRO) with a Buy and raises the price target from $100 to $115.